Edition:
United States

Insider Trading: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

84.64USD
4:00pm EDT
Change (% chg)

$0.73 (+0.87%)
Prev Close
$83.91
Open
$83.87
Day's High
$84.65
Day's Low
$83.81
Volume
1,235,220
Avg. Vol
959,924
52-wk High
$86.71
52-wk Low
$64.25

All Insider Trades
Trading Date Name Title Type Shares Traded Price
17 Sep 2017

Alvarez (Ralph)

Director Buy 132 $82.52
17 Sep 2017

Luciano (Juan R)

Director Buy 117 $82.52
14 Sep 2017

Lilly Endowment Inc

Beneficial Owner of More than 10% Class Sell 6,483 $83.32
14 Sep 2017

Lilly Endowment Inc

Beneficial Owner of More than 10% Class Sell 183,517 $82.50
30 Aug 2017

Lilly Endowment Inc

Beneficial Owner of More than 10% Class Sell 180,000 $81.06
20 Aug 2017

Alvarez (Ralph)

Director Buy 141 $77.38
20 Aug 2017

Luciano (Juan R)

Director Buy 125 $77.38
30 Jul 2017

Lilly Endowment Inc

Beneficial Owner of More than 10% Class Sell 216,521 $83.08
30 Jul 2017

Lilly Endowment Inc

Beneficial Owner of More than 10% Class Sell 3,479 $83.68
16 Jul 2017

Alvarez (Ralph)

Director Buy 131 $83.64
16 Jul 2017

Luciano (Juan R)

Director Buy 116 $83.64
21 Jun 2017

Lilly Endowment Inc

Beneficial Owner of More than 10% Class Sell 210,000 $84.43
19 Jun 2017

Lilly Endowment Inc

Beneficial Owner of More than 10% Class Sell 215,000 $83.05
18 Jun 2017

Luciano (Juan R)

Director Buy 117 $82.34
18 Jun 2017

Alvarez (Ralph)

Director Buy 133 $82.34
11 Jun 2017

Barnes Melissa S

Officer Sell 1,900 $80.78
8 Jun 2017

Harrington (Michael J)

General Counsel Sell 22,833 $79.97
14 May 2017

Alvarez (Ralph)

Director Buy 136 $80.30
14 May 2017

Luciano (Juan R)

Director Buy 120 $80.30
3 May 2017

Conterno (Enrique A)

Officer Sell 25,000 $82.76
16 Apr 2017

Luciano (Juan R)

Director Buy 117 $82.38
16 Apr 2017

Alvarez (Ralph)

Director Buy 133 $82.38
29 Mar 2017

Lilly Endowment Inc

Beneficial Owner of More than 10% Class Sell 210,000 $84.67
19 Mar 2017

Alvarez (Ralph)

Director Buy 130 $83.73
19 Mar 2017

Luciano (Juan R)

Director Buy 115 $83.73

Institutional Holders

% Shares Owned: 77.97%
# of Holders: 1,653
Total Shares Held: 858,454,397
3 Mo. Net Change: 2,347,547
# New Positions: 94
# Closed Positions: 83
# Increased Positions: 593
# Reduced Positions: 668
# Net Buyers: -75

Officers & Directors

Name Age Since Current Position

David Ricks

49 2017 Chairman of the Board, President, Chief Executive Officer

Derica Rice

52 2013 Chief Financial Officer, Executive Vice President - Global Services

Jan Lundberg

63 2010 Executive Vice President - Science and Technology, President - Lilly Research Laboratories

Melissa Barnes

48 2013 Senior Vice President - Enterprise Risk Management and Chief Ethics and Compliance Officer

Michael Harrington

54 2013 Senior Vice President, General Counsel

Stephen Fry

51 2011 Senior Vice President - Human Resources and Diversity

Enrique Conterno

50 2017 Senior Vice President and President - Lilly Diabetes and President - Lilly USA

Susan Mahony

52 2011 Senior Vice President and President - Lilly Oncology

Barton Peterson

58 2009 Senior Vice President - Corporate Affairs and Communications

Leigh Pusey

2017 Senior Vice President - Corporate Affairs and Communications

Jeffrey Simmons

49 2008 Senior Vice President and President - Elanco Animal Health

Fionnuala Walsh

57 2007 Senior Vice President - Global Quality

Alfonso Zulueta

54 2014 Senior Vice President and President - Emerging Markets

Ellen Marram

70 2013 Lead Independent Director

Raul Alvarez

61 2009 Independent Director

Katherine Baicker

45 2011 Independent Director

Carolyn Bertozzi

50 2017 Independent Director

Michael Eskew

67 2008 Independent Director

J. Erik Fyrwald

57 2005 Independent Director

R. David Hoover

71 2009 Independent Director

Jamere Jackson

48 2016 Independent Director

William Kaelin

59 2012 Independent Director

Juan Luciano

55 2016 Independent Director

Marschall Runge

62 2013 Independent Director

Kathi Seifert

67 1995 Independent Director

Jackson Tai

67 2013 Independent Director